APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Cilostazol

Compare research editions
View pricing & licenses

Selected research

Industry Research

Cilostazol Industry Research Report 2026

Report ID 173978150526 December 2025136 pages

Choose your research edition.

Industry ResearchCilostazol Industry Research Report 2026136 pages · $2,950 USDIndustry Growth & TrendsGlobal Cilostazol Industry Growth and Trends Forecast to 2032112 pages · $3,450 USDMarket StructureGlobal Cilostazol Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032199 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Cilostazol Market Outlook and Growth Opportunities 2026209 pages · $4,250 USDMarket Analysis & ForecastGlobal Cilostazol Market Analysis and Forecast 2026-2032209 pages · $4,950 USD

Market perspective

The global Cilostazol market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.

The North America market for Cilostazol is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.

The Europe market for Cilostazol is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.

Read the full market overview

The Asia Pacific market for Cilostazol is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.

Leading global manufacturers of Cilostazol include Chongqing Pharscin pharmaceutical, Zhejiang Weikang Pharmaceutical, Abbott, Takeda, Teva, Novartis, Mylan, Pfizer and GSK, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report quantifies the global Cilostazol market in terms of revenue (US$ million) and, where applicable, sales volume (K Units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.

It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10).

The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.

Key Companies & Market Share Insights

This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.

Cilostazol Market by Company

Chongqing Pharscin pharmaceutical

Zhejiang Weikang Pharmaceutical

Abbott

Takeda

Teva

Novartis

Mylan

Pfizer

GSK

Chengdu Leer Pharmaceutical

Yantai Yisheng Pharmaceutical

Squibb

Sandoz

Otsuka Pharmaceutical

Mayne Pharma

Hikma Pharmaceuticals

Cadila Pharmaceuticals

Bedford Laboratories

Cilostazol Segment by Type

Injection Cilostazol

Oral Cilostazol

Freeze-dried Powder Cilostazol

Cilostazol Segment by Application

Hospital

Clinic

Others

Cilostazol Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Cilostazol market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Cilostazol and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Cilostazol.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Research objectives, research methods, data sources, data cross-validation;

Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 3: Detailed analysis of Cilostazol manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.

Chapter 5: Production/output, value of Cilostazol by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.

Chapter 6: Consumption of Cilostazol in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.

Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 11: The main points and conclusions of the report.

More report detail

Tables and figures
List of Tables Table 1. Secondary Sources Table 2. Primary Sources Table 3. Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Market Value Comparison by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Cilostazol Volume and Revenue Market Size and CAGR of Manufacturers (2021 Versus 2025) Table 6. Global Cilostazol Sales (K Units) of Manufacturers (2021-2026) Table 7. Global Cilostazol Sales Market Share by Manufacturers (2021-2026) Table 8. Global Cilostazol Revenue of Manufacturers (2021-2026) Table 9. Global Cilostazol Revenue Share by Manufacturers (2021-2026) Table 10. Global Market Cilostazol Average Price (US$/Unit) of Manufacturers (2021-2026) Table 11. Global Cilostazol Industry Ranking, 2024 VS 2025 VS 2026 Table 12. Global Manufacturers of Cilostazol, Manufacturing Sites & Headquarters Table 13. Global Manufacturers of Cilostazol, Product Type & Application Table 14. Global Cilostazol Manufacturers Established Date Table 15. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 16. Global Cilostazol by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 17. Manufacturers Mergers & Acquisitions, Expansion Plans) Table 18. Chongqing Pharscin pharmaceutical Company Information Table 19. Chongqing Pharscin pharmaceutical Business Overview Table 20. Chongqing Pharscin pharmaceutical Cilostazol Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 21. Chongqing Pharscin pharmaceutical Cilostazol Product Portfolio Table 22. Chongqing Pharscin pharmaceutical Recent Developments Table 23. Zhejiang Weikang Pharmaceutical Company Information Table 24. Zhejiang Weikang Pharmaceutical Business Overview Table 25. Zhejiang Weikang Pharmaceutical Cilostazol Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 26. Zhejiang Weikang Pharmaceutical Cilostazol Product Portfolio Table 27. Zhejiang Weikang Pharmaceutical Recent Developments Table 28. Abbott Company Information Table 29. Abbott Business Overview Table 30. Abbott Cilostazol Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 31. Abbott Cilostazol Product Portfolio Table 32. Abbott Recent Developments Table 33. Takeda Company Information Table 34. Takeda Business Overview Table 35. Takeda Cilostazol Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 36. Takeda Cilostazol Product Portfolio Table 37. Takeda Recent Developments Table 38. Teva Company Information Table 39. Teva Business Overview Table 40. Teva Cilostazol Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 41. Teva Cilostazol Product Portfolio Table 42. Teva Recent Developments Table 43. Novartis Company Information Table 44. Novartis Business Overview Table 45. Novartis Cilostazol Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 46. Novartis Cilostazol Product Portfolio Table 47. Novartis Recent Developments Table 48. Mylan Company Information Table 49. Mylan Business Overview Table 50. Mylan Cilostazol Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 51. Mylan Cilostazol Product Portfolio Table 52. Mylan Recent Developments Table 53. Pfizer Company Information Table 54. Pfizer Business Overview Table 55. Pfizer Cilostazol Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 56. Pfizer Cilostazol Product Portfolio Table 57. Pfizer Recent Developments Table 58. GSK Company Information Table 59. GSK Business Overview Table 60. GSK Cilostazol Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 61. GSK Cilostazol Product Portfolio Table 62. GSK Recent Developments Table 63. Chengdu Leer Pharmaceutical Company Information Table 64. Chengdu Leer Pharmaceutical Business Overview Table 65. Chengdu Leer Pharmaceutical Cilostazol Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 66. Chengdu Leer Pharmaceutical Cilostazol Product Portfolio Table 67. Chengdu Leer Pharmaceutical Recent Developments Table 68. Yantai Yisheng Pharmaceutical Company Information Table 69. Yantai Yisheng Pharmaceutical Business Overview Table 70. Yantai Yisheng Pharmaceutical Cilostazol Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 71. Yantai Yisheng Pharmaceutical Cilostazol Product Portfolio Table 72. Yantai Yisheng Pharmaceutical Recent Developments Table 73. Squibb Company Information Table 74. Squibb Business Overview Table 75. Squibb Cilostazol Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 76. Squibb Cilostazol Product Portfolio Table 77. Squibb Recent Developments Table 78. Sandoz Company Information Table 79. Sandoz Business Overview Table 80. Sandoz Cilostazol Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 81. Sandoz Cilostazol Product Portfolio Table 82. Sandoz Recent Developments Table 83. Otsuka Pharmaceutical Company Information Table 84. Otsuka Pharmaceutical Business Overview Table 85. Otsuka Pharmaceutical Cilostazol Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 86. Otsuka Pharmaceutical Cilostazol Product Portfolio Table 87. Otsuka Pharmaceutical Recent Developments Table 88. Mayne Pharma Company Information Table 89. Mayne Pharma Business Overview Table 90. Mayne Pharma Cilostazol Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 91. Mayne Pharma Cilostazol Product Portfolio Table 92. Mayne Pharma Recent Developments Table 93. Hikma Pharmaceuticals Company Information Table 94. Hikma Pharmaceuticals Business Overview Table 95. Hikma Pharmaceuticals Cilostazol Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 96. Hikma Pharmaceuticals Cilostazol Product Portfolio Table 97. Hikma Pharmaceuticals Recent Developments Table 98. Cadila Pharmaceuticals Company Information Table 99. Cadila Pharmaceuticals Business Overview Table 100. Cadila Pharmaceuticals Cilostazol Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 101. Cadila Pharmaceuticals Cilostazol Product Portfolio Table 102. Cadila Pharmaceuticals Recent Developments Table 103. Bedford Laboratories Company Information Table 104. Bedford Laboratories Business Overview Table 105. Bedford Laboratories Cilostazol Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 106. Bedford Laboratories Cilostazol Product Portfolio Table 107. Bedford Laboratories Recent Developments Table 108. Global Cilostazol Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Table 109. Global Cilostazol Sales by Region (2021-2026) & (K Units) Table 110. Global Cilostazol Sales Market Share by Region (2021-2026) Table 111. Global Cilostazol Sales by Region (2027-2032) & (K Units) Table 112. Global Cilostazol Sales Market Share by Region (2027-2032) Table 113. Global Cilostazol Revenue by Region (2021-2026) & (US$ Million) Table 114. Global Cilostazol Revenue Market Share by Region (2021-2026) Table 115. Global Cilostazol Revenue by Region (2027-2032) & (US$ Million) Table 116. Global Cilostazol Revenue Market Share by Region (2027-2032) Table 117. North America Cilostazol Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 118. North America Cilostazol Sales by Country (2021-2026) & (K Units) Table 119. North America Cilostazol Sales by Country (2027-2032) & (K Units) Table 120. North America Cilostazol Revenue by Country (2021-2026) & (US$ Million) Table 121. North America Cilostazol Revenue by Country (2027-2032) & (US$ Million) Table 122. Europe Cilostazol Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 123. Europe Cilostazol Sales by Country (2021-2026) & (K Units) Table 124. Europe Cilostazol Sales by Country (2027-2032) & (K Units) Table 125. Europe Cilostazol Revenue by Country (2021-2026) & (US$ Million) Table 126. Europe Cilostazol Revenue by Country (2027-2032) & (US$ Million) Table 127. Asia Pacific Cilostazol Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 128. Asia Pacific Cilostazol Sales by Country (2021-2026) & (K Units) Table 129. Asia Pacific Cilostazol Sales by Country (2027-2032) & (K Units) Table 130. Asia Pacific Cilostazol Revenue by Country (2021-2026) & (US$ Million) Table 131. Asia Pacific Cilostazol Revenue by Country (2027-2032) & (US$ Million) Table 132. South America Cilostazol Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 133. South America Cilostazol Sales by Country (2021-2026) & (K Units) Table 134. South America Cilostazol Sales by Country (2027-2032) & (K Units) Table 135. South America Cilostazol Revenue by Country (2021-2026) & (US$ Million) Table 136. South America Cilostazol Revenue by Country (2027-2032) & (US$ Million) Table 137. Middle East and Africa Cilostazol Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 138. Middle East and Africa Cilostazol Sales by Country (2021-2026) & (K Units) Table 139. Middle East and Africa Cilostazol Sales by Country (2027-2032) & (K Units) Table 140. Middle East and Africa Cilostazol Revenue by Country (2021-2026) & (US$ Million) Table 141. Middle East and Africa Cilostazol Revenue by Country (2027-2032) & (US$ Million) Table 142. Global Cilostazol Sales by Type (2021-2026) & (K Units) Table 143. Global Cilostazol Sales by Type (2027-2032) & (K Units) Table 144. Global Cilostazol Sales Market Share by Type (2021-2026) Table 145. Global Cilostazol Sales Market Share by Type (2027-2032) Table 146. Global Cilostazol Revenue by Type (2021-2026) & (US$ Million) Table 147. Global Cilostazol Revenue by Type (2027-2032) & (US$ Million) Table 148. Global Cilostazol Revenue Market Share by Type (2021-2026) Table 149. Global Cilostazol Revenue Market Share by Type (2027-2032) Table 150. Global Cilostazol Price by Type (2021-2026) & (US$/Unit) Table 151. Global Cilostazol Price by Type (2027-2032) & (US$/Unit) Table 152. Global Cilostazol Sales by Application (2021-2026) & (K Units) Table 153. Global Cilostazol Sales by Application (2027-2032) & (K Units) Table 154. Global Cilostazol Sales Market Share by Application (2021-2026) Table 155. Global Cilostazol Sales Market Share by Application (2027-2032) Table 156. Global Cilostazol Revenue by Application (2021-2026) & (US$ Million) Table 157. Global Cilostazol Revenue by Application (2027-2032) & (US$ Million) Table 158. Global Cilostazol Revenue Market Share by Application (2021-2026) Table 159. Global Cilostazol Revenue Market Share by Application (2027-2032) Table 160. Global Cilostazol Price by Application (2021-2026) & (US$/Unit) Table 161. Global Cilostazol Price by Application (2027-2032) & (US$/Unit) Table 162. Key Raw Materials Table 163. Raw Materials Key Suppliers Table 164. Cilostazol Distributors List Table 165. Cilostazol Customers List Table 166. Cilostazol Industry Trends Table 167. Cilostazol Industry Drivers Table 168. Cilostazol Industry Restraints Table 169. Authors List of This Report List of Figures Figure 1. Research Methodology Figure 2. Research Process Figure 3. Key Executives Interviewed Figure 4. Cilostazol Product Image Figure 5. Global Cilostazol Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 6. Global Cilostazol Market Size (2021-2032) & (US$ Million) Figure 7. Global Cilostazol Sales (2021-2032) & (K Units) Figure 8. Global Cilostazol Average Price (US$/Unit) & (2021-2032) Figure 9. Injection Cilostazol Product Image Figure 10. Oral Cilostazol Product Image Figure 11. Freeze-dried Powder Cilostazol Product Image Figure 12. Hospital Product Image Figure 13. Clinic Product Image Figure 14. Others Product Image Figure 15. Global Cilostazol Revenue Share by Manufacturers in 2025 Figure 16. Global Manufacturers of Cilostazol, Manufacturing Sites & Headquarters Figure 17. Global Top 5 and 10 Cilostazol Players Market Share by Revenue in 2025 Figure 18. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 19. Global Cilostazol Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Figure 20. Global Cilostazol Sales by Region in 2025 Figure 21. Global Cilostazol Revenue by Region in 2025 Figure 22. North America Cilostazol Market Size by Country in 2025 Figure 23. North America Cilostazol Sales Market Share by Country (2021-2032) Figure 24. North America Cilostazol Revenue Market Share by Country (2021-2032) Figure 25. United States Cilostazol Revenue Growth Rate (2021-2032) & (US$ Million) Figure 26. Canada Cilostazol Revenue Growth Rate (2021-2032) & (US$ Million) Figure 27. Mexico Cilostazol Revenue Growth Rate (2021-2032) & (US$ Million) Figure 28. Europe Cilostazol Market Size by Country in 2025 Figure 29. Europe Cilostazol Sales Market Share by Country (2021-2032) Figure 30. Europe Cilostazol Revenue Market Share by Country (2021-2032) Figure 31. Germany Cilostazol Revenue Growth Rate (2021-2032) & (US$ Million) Figure 32. France Cilostazol Revenue Growth Rate (2021-2032) & (US$ Million) Figure 33. U.K. Cilostazol Revenue Growth Rate (2021-2032) & (US$ Million) Figure 34. Italy Cilostazol Revenue Growth Rate (2021-2032) & (US$ Million) Figure 35. Russia Cilostazol Revenue Growth Rate (2021-2032) & (US$ Million) Figure 36. Spain Cilostazol Revenue Growth Rate (2021-2032) & (US$ Million) Figure 37. Netherlands Cilostazol Revenue Growth Rate (2021-2032) & (US$ Million) Figure 38. Switzerland Cilostazol Revenue Growth Rate (2021-2032) & (US$ Million) Figure 39. Sweden Cilostazol Revenue Growth Rate (2021-2032) & (US$ Million) Figure 40. Poland Cilostazol Revenue Growth Rate (2021-2032) & (US$ Million) Figure 41. Asia Pacific Cilostazol Market Size by Country in 2025 Figure 42. Asia Pacific Cilostazol Sales Market Share by Country (2021-2032) Figure 43. Asia Pacific Cilostazol Revenue Market Share by Country (2021-2032) Figure 44. China Cilostazol Revenue Growth Rate (2021-2032) & (US$ Million) Figure 45. Japan Cilostazol Revenue Growth Rate (2021-2032) & (US$ Million) Figure 46. South Korea Cilostazol Revenue Growth Rate (2021-2032) & (US$ Million) Figure 47. India Cilostazol Revenue Growth Rate (2021-2032) & (US$ Million) Figure 48. Australia Cilostazol Revenue Growth Rate (2021-2032) & (US$ Million) Figure 49. Taiwan Cilostazol Revenue Growth Rate (2021-2032) & (US$ Million) Figure 50. Southeast Asia Cilostazol Revenue Growth Rate (2021-2032) & (US$ Million) Figure 51. Southeast Asia Cilostazol Revenue Growth Rate (2021-2032) & (US$ Million) Figure 52. South America Cilostazol Market Size by Country in 2025 Figure 53. South America Cilostazol Sales Market Share by Country (2021-2032) Figure 54. South America Cilostazol Revenue Market Share by Country (2021-2032) Figure 55. Brazil Cilostazol Revenue Growth Rate (2021-2032) & (US$ Million) Figure 56. Argentina Cilostazol Revenue Growth Rate (2021-2032) & (US$ Million) Figure 57. Chile Cilostazol Revenue Growth Rate (2021-2032) & (US$ Million) Figure 58. Middle East and Africa Cilostazol Market Size by Country in 2025 Figure 59. Middle East and Africa Cilostazol Sales Market Share by Country (2021-2032) Figure 60. Middle East and Africa Cilostazol Revenue Market Share by Country (2021-2032) Figure 61. Egypt Cilostazol Revenue Growth Rate (2021-2032) & (US$ Million) Figure 62. South Africa Cilostazol Revenue Growth Rate (2021-2032) & (US$ Million) Figure 63. Israel Cilostazol Revenue Growth Rate (2021-2032) & (US$ Million) Figure 64. Türkiye Cilostazol Revenue Growth Rate (2021-2032) & (US$ Million) Figure 65. GCC Countries Cilostazol Revenue Growth Rate (2021-2032) & (US$ Million) Figure 66. Global Cilostazol Sales Market Share by Type (2021-2032) Figure 67. Global Cilostazol Revenue Market Share by Type (2021-2032) Figure 68. Global Cilostazol Price (US$/Unit) by Type (2021-2032) Figure 69. Global Cilostazol Sales Market Share by Application (2021-2032) Figure 70. Global Cilostazol Revenue Market Share by Application (2021-2032) Figure 71. Global Cilostazol Price (US$/Unit) by Application (2021-2032) Figure 72. Cilostazol Value Chain Figure 73. Cilostazol Production Mode & Process Figure 74. Direct Comparison with Distribution Share Figure 75. Distributors Profiles Figure 76. Cilostazol Industry Opportunities and Challenges

Scope & coverage.

Types
  • Injection Cilostazol
  • Oral Cilostazol
  • Freeze-dried Powder Cilostazol
Applications
  • Hospital
  • Clinic
  • Others
Companies covered
  • Chongqing Pharscin pharmaceutical
  • Zhejiang Weikang Pharmaceutical
  • Abbott
  • Takeda
  • Teva
  • Novartis
  • Mylan
  • Pfizer
  • GSK
  • Chengdu Leer Pharmaceutical
  • Yantai Yisheng Pharmaceutical
  • Squibb
  • Sandoz
  • Otsuka Pharmaceutical
  • Mayne Pharma
  • Hikma Pharmaceuticals
  • Cadila Pharmaceuticals
  • Bedford Laboratories

Inside the report.

1 Preface
  1. 1.1 Scope of Report
  2. 1.2 Reasons for Doing This Study
  3. 1.3 Research Methodology
  4. 1.4 Research Process
  5. 1.5 Data Source
  6. 1.5.1 Secondary Sources
  7. 1.5.2 Primary Sources
2 Market Overview
  1. 2.1 Product Definition
  2. 2.2 Global Market Growth Prospects
  3. 2.2.1 Global Cilostazol Market Size (2021-2032)
  4. 2.2.2 Global Cilostazol Sales (2021-2032)
  5. 2.2.3 Global Cilostazol Market Average Price (2021-2032)
  6. 2.3 Cilostazol by Type
  7. 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
  8. 2.3.2 Injection Cilostazol
  9. 2.3.3 Oral Cilostazol
  10. 2.3.4 Freeze-dried Powder Cilostazol
  11. 2.4 Cilostazol by Application
  12. 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
  13. 2.4.2 Hospital
  14. 2.4.3 Clinic
  15. 2.4.4 Others
3 Market Competitive Landscape by Manufacturers
  1. 3.1 Global Cilostazol Market Competitive Situation by Manufacturers (2021 Versus 2025)
  2. 3.2 Global Cilostazol Sales (K Units) of Manufacturers (2021-2026)
  3. 3.3 Global Cilostazol Revenue of Manufacturers (2021-2026)
  4. 3.4 Global Cilostazol Average Price by Manufacturers (2021-2026)
  5. 3.5 Global Cilostazol Industry Ranking, 2024 VS 2025 VS 2026
  6. 3.6 Global Manufacturers of Cilostazol, Manufacturing Sites & Headquarters
  7. 3.7 Global Manufacturers of Cilostazol, Product Type & Application
  8. 3.8 Global Manufacturers of Cilostazol, Established Date
  9. 3.9 Global Cilostazol Market CR5 and HHI
  10. 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
  1. 4.1 Chongqing Pharscin pharmaceutical
  2. 4.1.1 Chongqing Pharscin pharmaceutical Company Information
  3. 4.1.2 Chongqing Pharscin pharmaceutical Business Overview
  4. 4.1.3 Chongqing Pharscin pharmaceutical Cilostazol Sales, Revenue and Gross Margin (2021-2026)
  5. 4.1.4 Chongqing Pharscin pharmaceutical Cilostazol Product Portfolio
  6. 4.1.5 Chongqing Pharscin pharmaceutical Recent Developments
  7. 4.2 Zhejiang Weikang Pharmaceutical
  8. 4.2.1 Zhejiang Weikang Pharmaceutical Company Information
  9. 4.2.2 Zhejiang Weikang Pharmaceutical Business Overview
  10. 4.2.3 Zhejiang Weikang Pharmaceutical Cilostazol Sales, Revenue and Gross Margin (2021-2026)
  11. 4.2.4 Zhejiang Weikang Pharmaceutical Cilostazol Product Portfolio
  12. 4.2.5 Zhejiang Weikang Pharmaceutical Recent Developments
  13. 4.3 Abbott
  14. 4.3.1 Abbott Company Information
  15. 4.3.2 Abbott Business Overview
  16. 4.3.3 Abbott Cilostazol Sales, Revenue and Gross Margin (2021-2026)
  17. 4.3.4 Abbott Cilostazol Product Portfolio
  18. 4.3.5 Abbott Recent Developments
  19. 4.4 Takeda
  20. 4.4.1 Takeda Company Information
  21. 4.4.2 Takeda Business Overview
  22. 4.4.3 Takeda Cilostazol Sales, Revenue and Gross Margin (2021-2026)
  23. 4.4.4 Takeda Cilostazol Product Portfolio
  24. 4.4.5 Takeda Recent Developments
  25. 4.5 Teva
  26. 4.5.1 Teva Company Information
  27. 4.5.2 Teva Business Overview
  28. 4.5.3 Teva Cilostazol Sales, Revenue and Gross Margin (2021-2026)
  29. 4.5.4 Teva Cilostazol Product Portfolio
  30. 4.5.5 Teva Recent Developments
  31. 4.6 Novartis
  32. 4.6.1 Novartis Company Information
  33. 4.6.2 Novartis Business Overview
  34. 4.6.3 Novartis Cilostazol Sales, Revenue and Gross Margin (2021-2026)
  35. 4.6.4 Novartis Cilostazol Product Portfolio
  36. 4.6.5 Novartis Recent Developments
  37. 4.7 Mylan
  38. 4.7.1 Mylan Company Information
  39. 4.7.2 Mylan Business Overview
  40. 4.7.3 Mylan Cilostazol Sales, Revenue and Gross Margin (2021-2026)
  41. 4.7.4 Mylan Cilostazol Product Portfolio
  42. 4.7.5 Mylan Recent Developments
  43. 4.8 Pfizer
  44. 4.8.1 Pfizer Company Information
  45. 4.8.2 Pfizer Business Overview
  46. 4.8.3 Pfizer Cilostazol Sales, Revenue and Gross Margin (2021-2026)
  47. 4.8.4 Pfizer Cilostazol Product Portfolio
  48. 4.8.5 Pfizer Recent Developments
  49. 4.9 GSK
  50. 4.9.1 GSK Company Information
  51. 4.9.2 GSK Business Overview
  52. 4.9.3 GSK Cilostazol Sales, Revenue and Gross Margin (2021-2026)
  53. 4.9.4 GSK Cilostazol Product Portfolio
  54. 4.9.5 GSK Recent Developments
  55. 4.10 Chengdu Leer Pharmaceutical
  56. 4.10.1 Chengdu Leer Pharmaceutical Company Information
  57. 4.10.2 Chengdu Leer Pharmaceutical Business Overview
  58. 4.10.3 Chengdu Leer Pharmaceutical Cilostazol Sales, Revenue and Gross Margin (2021-2026)
  59. 4.10.4 Chengdu Leer Pharmaceutical Cilostazol Product Portfolio
  60. 4.10.5 Chengdu Leer Pharmaceutical Recent Developments
  61. 4.11 Yantai Yisheng Pharmaceutical
  62. 4.11.1 Yantai Yisheng Pharmaceutical Company Information
  63. 4.11.2 Yantai Yisheng Pharmaceutical Business Overview
  64. 4.11.3 Yantai Yisheng Pharmaceutical Cilostazol Sales, Revenue and Gross Margin (2021-2026)
  65. 4.11.4 Yantai Yisheng Pharmaceutical Cilostazol Product Portfolio
  66. 4.11.5 Yantai Yisheng Pharmaceutical Recent Developments
  67. 4.12 Squibb
  68. 4.12.1 Squibb Company Information
  69. 4.12.2 Squibb Business Overview
  70. 4.12.3 Squibb Cilostazol Sales, Revenue and Gross Margin (2021-2026)
  71. 4.12.4 Squibb Cilostazol Product Portfolio
  72. 4.12.5 Squibb Recent Developments
  73. 4.13 Sandoz
  74. 4.13.1 Sandoz Company Information
  75. 4.13.2 Sandoz Business Overview
  76. 4.13.3 Sandoz Cilostazol Sales, Revenue and Gross Margin (2021-2026)
  77. 4.13.4 Sandoz Cilostazol Product Portfolio
  78. 4.13.5 Sandoz Recent Developments
  79. 4.14 Otsuka Pharmaceutical
  80. 4.14.1 Otsuka Pharmaceutical Company Information
  81. 4.14.2 Otsuka Pharmaceutical Business Overview
  82. 4.14.3 Otsuka Pharmaceutical Cilostazol Sales, Revenue and Gross Margin (2021-2026)
  83. 4.14.4 Otsuka Pharmaceutical Cilostazol Product Portfolio
  84. 4.14.5 Otsuka Pharmaceutical Recent Developments
  85. 4.15 Mayne Pharma
  86. 4.15.1 Mayne Pharma Company Information
  87. 4.15.2 Mayne Pharma Business Overview
  88. 4.15.3 Mayne Pharma Cilostazol Sales, Revenue and Gross Margin (2021-2026)
  89. 4.15.4 Mayne Pharma Cilostazol Product Portfolio
  90. 4.15.5 Mayne Pharma Recent Developments
  91. 4.16 Hikma Pharmaceuticals
  92. 4.16.1 Hikma Pharmaceuticals Company Information
  93. 4.16.2 Hikma Pharmaceuticals Business Overview
  94. 4.16.3 Hikma Pharmaceuticals Cilostazol Sales, Revenue and Gross Margin (2021-2026)
  95. 4.16.4 Hikma Pharmaceuticals Cilostazol Product Portfolio
  96. 4.16.5 Hikma Pharmaceuticals Recent Developments
  97. 4.17 Cadila Pharmaceuticals
  98. 4.17.1 Cadila Pharmaceuticals Company Information
  99. 4.17.2 Cadila Pharmaceuticals Business Overview
  100. 4.17.3 Cadila Pharmaceuticals Cilostazol Sales, Revenue and Gross Margin (2021-2026)
  101. 4.17.4 Cadila Pharmaceuticals Cilostazol Product Portfolio
  102. 4.17.5 Cadila Pharmaceuticals Recent Developments
  103. 4.18 Bedford Laboratories
  104. 4.18.1 Bedford Laboratories Company Information
  105. 4.18.2 Bedford Laboratories Business Overview
  106. 4.18.3 Bedford Laboratories Cilostazol Sales, Revenue and Gross Margin (2021-2026)
  107. 4.18.4 Bedford Laboratories Cilostazol Product Portfolio
  108. 4.18.5 Bedford Laboratories Recent Developments
5 Global Cilostazol Market Scenario by Region
  1. 5.1 Global Cilostazol Market Size by Region: 2021 VS 2025 VS 2032
  2. 5.2 Global Cilostazol Sales by Region: 2021-2032
  3. 5.2.1 Global Cilostazol Sales by Region: 2021-2026
  4. 5.2.2 Global Cilostazol Sales by Region: 2027-2032
  5. 5.3 Global Cilostazol Revenue by Region: 2021-2032
  6. 5.3.1 Global Cilostazol Revenue by Region: 2021-2026
  7. 5.3.2 Global Cilostazol Revenue by Region: 2027-2032
  8. 5.4 North America Cilostazol Market Facts & Figures by Country
  9. 5.4.1 North America Cilostazol Market Size by Country: 2021 VS 2025 VS 2032
  10. 5.4.2 North America Cilostazol Sales by Country (2021-2032)
  11. 5.4.3 North America Cilostazol Revenue by Country (2021-2032)
  12. 5.4.4 United States
  13. 5.4.5 Canada
  14. 5.4.6 Mexico
  15. 5.5 Europe Cilostazol Market Facts & Figures by Country
  16. 5.5.1 Europe Cilostazol Market Size by Country: 2021 VS 2025 VS 2032
  17. 5.5.2 Europe Cilostazol Sales by Country (2021-2032)
  18. 5.5.3 Europe Cilostazol Revenue by Country (2021-2032)
  19. 5.5.4 Germany
  20. 5.5.5 France
  21. 5.5.6 U.K.
  22. 5.5.7 Italy
  23. 5.5.8 Russia
  24. 5.5.9 Spain
  25. 5.5.10 Netherlands
  26. 5.5.11 Switzerland
  27. 5.5.12 Sweden
  28. 5.5.13 Poland
  29. 5.6 Asia Pacific Cilostazol Market Facts & Figures by Country
  30. 5.6.1 Asia Pacific Cilostazol Market Size by Country: 2021 VS 2025 VS 2032
  31. 5.6.2 Asia Pacific Cilostazol Sales by Country (2021-2032)
  32. 5.6.3 Asia Pacific Cilostazol Revenue by Country (2021-2032)
  33. 5.6.4 China
  34. 5.6.5 Japan
  35. 5.6.6 South Korea
  36. 5.6.7 India
  37. 5.6.8 Australia
  38. 5.6.9 Taiwan
  39. 5.6.10 Southeast Asia
  40. 5.7 South America Cilostazol Market Facts & Figures by Country
  41. 5.7.1 South America Cilostazol Market Size by Country: 2021 VS 2025 VS 2032
  42. 5.7.2 South America Cilostazol Sales by Country (2021-2032)
  43. 5.7.3 South America Cilostazol Revenue by Country (2021-2032)
  44. 5.7.4 Brazil
  45. 5.7.5 Argentina
  46. 5.7.6 Chile
  47. 5.8 Middle East and Africa Cilostazol Market Facts & Figures by Country
  48. 5.8.1 Middle East and Africa Cilostazol Market Size by Country: 2021 VS 2025 VS 2032
  49. 5.8.2 Middle East and Africa Cilostazol Sales by Country (2021-2032)
  50. 5.8.3 Middle East and Africa Cilostazol Revenue by Country (2021-2032)
  51. 5.8.4 Egypt
  52. 5.8.5 South Africa
  53. 5.8.6 Israel
  54. 5.8.7 Türkiye
  55. 5.8.8 GCC Countries
6 Segment by Type
  1. 6.1 Global Cilostazol Sales by Type (2021-2032)
  2. 6.1.1 Global Cilostazol Sales by Type (2021-2032) & (K Units)
  3. 6.1.2 Global Cilostazol Sales Market Share by Type (2021-2032)
  4. 6.2 Global Cilostazol Revenue by Type (2021-2032)
  5. 6.2.1 Global Cilostazol Sales by Type (2021-2032) & (US$ Million)
  6. 6.2.2 Global Cilostazol Revenue Market Share by Type (2021-2032)
  7. 6.3 Global Cilostazol Price by Type (2021-2032)
7 Segment by Application
  1. 7.1 Global Cilostazol Sales by Application (2021-2032)
  2. 7.1.1 Global Cilostazol Sales by Application (2021-2032) & (K Units)
  3. 7.1.2 Global Cilostazol Sales Market Share by Application (2021-2032)
  4. 7.2 Global Cilostazol Revenue by Application (2021-2032)
  5. 7.2.1 Global Cilostazol Sales by Application (2021-2032) & (US$ Million)
  6. 7.2.2 Global Cilostazol Revenue Market Share by Application (2021-2032)
  7. 7.3 Global Cilostazol Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
  1. 8.1 Cilostazol Value Chain Analysis
  2. 8.1.1 Cilostazol Key Raw Materials
  3. 8.1.2 Raw Materials Key Suppliers
  4. 8.1.3 Cilostazol Production Mode & Process
  5. 8.2 Cilostazol Sales Channels Analysis
  6. 8.2.1 Direct Comparison with Distribution Share
  7. 8.2.2 Cilostazol Distributors
  8. 8.2.3 Cilostazol Customers
9 Global Cilostazol Analyzing Market Dynamics
  1. 9.1 Cilostazol Industry Trends
  2. 9.2 Cilostazol Industry Drivers
  3. 9.3 Cilostazol Industry Opportunities and Challenges
  4. 9.4 Cilostazol Industry Restraints
10 Report Conclusion
    11 Disclaimer

      GET THE RESEARCH

      Choose your license.

      Choose who needs access.
      All options are for this report and research series.

      Compare access permissions.

      Single User License
      One named user. Individual access.
      Multi User License
      Up to 5 users in the same department.
      Enterprise License
      Organization-wide access within the agreed license.

      Access applies to the purchased edition. Later editions are separate purchases.

      License options
      $2,950USD
      Buy now

      PDF by email within 3–5 working days after payment confirmation.

      Talk to an analyst
      APO Research, Inc.
      Talk to an analyst